An international, randomized, placebo-controlled, phase 2b clinical trial of intepirdine for dementia with Lewy bodies (HEADWAY-DLB)

Frederick M. Lang, Daniel Y. Kwon, Dag Aarsland, Brad Boeve, Babak Tousi, Mark Harnett, Yi Mo, Marwan Noel Sabbagh*

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

12 Citations (Scopus)

Fingerprint

Dive into the research topics of 'An international, randomized, placebo-controlled, phase 2b clinical trial of intepirdine for dementia with Lewy bodies (HEADWAY-DLB)'. Together they form a unique fingerprint.

Medicine and Dentistry